Directly coaxial 3D bioprinting of large-scale vascularized tissue constructs.

Biofabrication
Lei ShaoYong He

Abstract

Three-dimensional (3D) bioprinting of soft large-scale tissues in vitro is still a big challenge due to two limitations, (i) the lack of an effective way to print fine nutrient delivery channels (NDCs) inside the cell-laden structures above the millimetre level; (ii) the need for a feasible strategy to vascularize NDCs. Here, a novel 3D bioprinting method is reported to directly print cell-laden structures with effectively vascularized NDCs. Bioinks with desired tissue cells and endothelial cells (ECs) are separately and simultaneously printed from the outside (mixed with GelMA) and inside (mixed with gelatin) of a coaxial nozzle. As a result, the printed large-scale tissue consists of sheath-core fibers. At the same time, when the core fibers are dissolved to generate channels, the ECs deposit and adhere to the channels automatically. With this method, 3D cell-laden, vascularized tissue constructs (⩾1 cm) with a long-term culture (⩾20 d) are firstly reported. Specifically, vascularized cancer tissue constructs and osteogenic tissue constructs were generated. Considering the above advantages, this advanced bioprinting strategy has significant potential for building large-scale vascularized tissue constructs for applications in ...Continue Reading

References

Sep 23, 2000·Nature·P Carmeliet, R K Jain
Apr 12, 2003·Nature Materials·Daniel TherriaultJennifer A Lewis
Mar 2, 2005·Tissue Engineering·Craig K GriffithSteven C George
Jul 9, 2005·Nature Biotechnology·Rakesh K JainDai Fukumura
Jul 1, 2008·Trends in Biotechnology·Jeroen RouwkemaClemens A van Blitterswijk
Aug 12, 2009·Biomaterials·Cyrille NorotteGabor Forgacs
Apr 27, 2010·Biomaterials·Jason W NicholAli Khademhosseini
Mar 26, 2011·Advanced Materials·Willie WuJennifer A Lewis
Aug 22, 2012·Advanced Functional Materials·Ying-Chieh ChenAli Khademhosseini
Oct 31, 2012·Advanced Materials·Christopher J HansenJennifer A Lewis
Feb 20, 2014·Advanced Materials·David B KoleskyJennifer A Lewis
May 27, 2014·Lab on a Chip·Luiz E BertassoniAli Khademhosseini
Nov 27, 2015·Advanced Materials·Cristina ColosiAli Khademhosseini
Mar 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·David B KoleskyJennifer A Lewis
Aug 24, 2016·Biomaterials·Weitao JiaAli Khademhosseini
Jun 14, 2017·Scientific Reports·Avathamsa AthirasalaLuiz E Bertassoni
Mar 2, 2018·Biomaterials Science·P Selcan Gungor-OzkerimMehmet Remzi Dokmeci
Sep 25, 2018·Biomaterials·Amir K MiriAli Khademhosseini
Dec 18, 2019·Advanced Healthcare Materials·Lei ShaoYong He

❮ Previous
Next ❯

Citations

Oct 20, 2020·Advanced Healthcare Materials·Liang MaHuayong Yang
Nov 4, 2020·Biology Direct·Lorenzo BovaElisa Cimetta
Mar 18, 2021·APL Bioengineering·Shen Ji, Murat Guvendiren
Oct 1, 2020·Bioactive Materials·Andrew KjarYu Huang
Jun 15, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Baosen TanXiaoming Li
Aug 6, 2021·Advanced Science·Alessandra DellaquilaTeresa Simon-Yarza
Aug 20, 2021·Nano-micro Letters·Maedeh RahimnejadRajender S Varma
Oct 2, 2021·Advanced Materials·Hossein RavanbakhshYu Shrike Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved